Hewitt L Arthur 4

4 · Chelsea Therapeutics International, Ltd. · Filed Jan 13, 2011

Form 4

Period: 2011-01-11

Vice Pres. of Drug Development

Transactions

Award
Stock Option (Right to Buy)
2011-01-11+50,000→ 50,000 total
Exercise: $7.72Exp: 2021-01-11→ Common Stock (50,000 underlying)

Holdings

Common Stock
(indirect: By Spouse)
58,683
Stock Option (Right to Buy)
Exercise: $2.62Exp: 2015-01-10→ Common Stock (68,923 underlying)
68,923
Stock Option (Right to Buy)
Exercise: $2.96Exp: 2020-01-19→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $6.50Exp: 2018-01-24→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $1.78Exp: 2019-01-22→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $5.68Exp: 2017-02-06→ Common Stock (50,000 underlying)
50,000
Stock Option (Right to Buy)
Exercise: $3.26Exp: 2016-01-19→ Common Stock (50,000 underlying)
50,000

Footnotes (7)

[F1]Option vests in four equal annual installments beginning on January 11, 2012.
[F2]Option vests in four equal annual installments beginning on January 19, 2011.
[F3]Option vests in four equal annual installments beginning on January 22, 2010.
[F4]Option vests in four equal annual installments beginning on January 24, 2009.
[F5]Option vests in four equal annual installments beginning on February 6, 2008.
[F6]Option vests in four equal annual installments beginning on January 19, 2007.
[F7]Option vested in four equal annual installments beginning on January 10, 2006.

Documents

1 file